Hydroxocobalamin (Watson Laboratories, Inc.)
Welcome to the PulseAid listing for the Hydroxocobalamin drug offered from Watson Laboratories, Inc.. This Antidote [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Watson Laboratories, Inc. |
| NON-PROPRIETARY NAME: | Hydroxocobalamin |
| SUBSTANCE NAME: | HYDROXOCOBALAMIN ACETATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antidote [EPC] |
| ROUTE: | INTRAMUSCULAR |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2010-11-12 |
| END MARKETING DATE: | 0000-00-00 |
Hydroxocobalamin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Hydroxocobalamin from Watson Laboratories, Inc. |
| LABELER NAME: | Watson Laboratories, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1000(ug/mL) |
| START MARKETING DATE: | 2010-11-12 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0591-2888_8a32969f-18b7-4a22-8566-928b31b366f1 |
| PRODUCT NDC: | 0591-2888 |
| APPLICATION NUMBER: | ANDA085998 |
Other HYDROXOCOBALAMIN ACETATE Pharmaceutical Manufacturers / Labelers:
